This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, P. P.
Right arrow Articles by Gordon, Y. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, P. P.
Right arrow Articles by Gordon, Y. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 2008, p. 3232-3236, Vol. 46, No. 10
0095-1137/08/$08.00+0     doi:10.1128/JCM.00908-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Validation of Real-Time PCR for Laboratory Diagnosis of Acanthamoeba Keratitis{triangledown}

Paul P. Thompson,* Regis P. Kowalski, Robert M. Q. Shanks, and Y. Jerold Gordon

The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213

Received 12 May 2008/ Returned for modification 25 July 2008/ Accepted 1 August 2008

Confirmation of Acanthamoeba keratitis by laboratory diagnosis is the first step in the treatment of this vision-threatening disease. Two real-time PCR TaqMan protocols (the Rivière and Qvarnstrom assays) were developed for the detection of genus-specific Acanthamoeba DNA but lacked clinical validation. We have adapted these assays for the Cepheid SmartCycler II system (i) by determining their real-time PCR limits of detection and amplification efficiencies, (ii) by determining their ability to detect trophozoites and cysts, and (iii) by testing a battery of positive and negative samples. We also examined the inhibitory effects of a number of commonly used topical ophthalmic drugs on real-time PCR. The results of the real-time PCR limit of detection and amplification efficiency of the Rivière and Qvarnstrom assays were 11.3 DNA copies/10 µl and 94% and 43.8 DNA copies/10 µl and 92%, respectively. Our extraction protocol enabled us to detect 0.7 Acanthamoeba cysts/10 µl and 2.3 Acanthamoeba trophozoites/10 µl by both real-time PCR assays. The overall agreement between the assays was 97.0%. The clinical sensitivity and specificity of both real-time PCR assays based on culture were 100% (7 of 7) and 100% (37 of 37), respectively. Polyhexamethylene biguanide was the only topical drug that demonstrated PCR inhibition, with a minimal inhibitory dilution of 1/640 and an amplification efficiency of 72.7%. Four clinical samples were Acanthamoeba culture negative and real-time PCR positive. Our results indicate that both real-time PCR assays could be used to diagnose Acanthamoeba keratitis. Polyhexamethylene biguanide can inhibit PCR, and we suggest that specimen collection occur prior to topical treatment to avoid possible false-negative results.

* Corresponding author. Mailing address: UPMC Eye Center, Ophthalmic Microbiology Laboratory, Rm. 643, 203 Lothrop St., Pittsburgh, PA 15213. Phone: (412) 647-7211. Fax: (412) 647-5331. E-mail: thompsonpp{at}upmc.edu

{triangledown} Published ahead of print on 13 August 2008.

Journal of Clinical Microbiology, October 2008, p. 3232-3236, Vol. 46, No. 10
0095-1137/08/$08.00+0     doi:10.1128/JCM.00908-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»